Analyst Ratings For NASDAQ:AXSM – Axsome Therapeutics (NASDAQ:AXSM)
Today, HC Wainwright initiated coverage on NASDAQ:AXSM – Axsome Therapeutics (NASDAQ:AXSM) with a Buy with a price target of $10.00.
Some recent analyst ratings include
- 6/7/2018-HC Wainwright initiated coverage with a Buy rating.
- 4/29/2018-BTIG Research Reiterated Rating of Buy.
- 7/26/2017-LADENBURG THALM/SH SH Reiterated Rating of Buy.
- 6/20/2017-Aegis Reiterated Rating of Buy.
- 10/3/2016-Brean Capital initiated coverage with a Buy rating.
Recent Insider Trading Activity For NASDAQ:AXSM – Axsome Therapeutics (NASDAQ:AXSM)
NASDAQ:AXSM – Axsome Therapeutics (NASDAQ:AXSM) has insider ownership of 34.30% and institutional ownership of 16.49%.
- On 12/23/2015 Randall Kaye, Insider, bought 1,000 with an average share price of $9.03 per share and the total transaction amounting to $9,030.00.
Recent Trading Activity for NASDAQ:AXSM – Axsome Therapeutics (NASDAQ:AXSM)
Shares of NASDAQ:AXSM – Axsome Therapeutics closed the previous trading session at 3.72 up +0.12 3.47% with shares trading hands.